journal
MENU ▼
Read by QxMD icon Read
search

Journal of Oncology Practice

journal
https://www.readbyqxmd.com/read/30216125/cns-metastases-in-epidermal-growth-factor-receptor-mutation-positive-non-small-cell-lung-cancer-impact-on-health-resource-utilization
#1
Negar Chooback, Shilo Lefresne, Sally C Lau, Cheryl Ho
PURPOSE: Patients with epidermal growth factor receptor (EGFR) mutation-positive (EGFRm) non-small-cell lung cancer commonly experience disease progression in the CNS. Here, we assess the impact of CNS disease on resource utilization and outcomes in patients who are EGFRm. METHODS: We completed a retrospective review of all advanced patients who were EGFRm, referred to BC Cancer, and treated with a first- and/or second-generation EGFR tyrosine kinase inhibitor from 2010 to 2015...
September 14, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30207855/clinical-challenges-and-opportunities-with-current-electronic-health-records-practicing-oncologists-perspective
#2
Debra Patt, Philip Stella, Linda Bosserman
No abstract text is available yet for this article.
September 12, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30207854/times-to-diagnosis-and-treatment-of-lung-cancer-in-new-south-wales-australia-a-multicenter-medicare-data-linkage-study
#3
Ashanya Malalasekera, Prunella L Blinman, Haryana M Dhillon, Natalie A Stefanic, Peter Grimison, Ankit Jain, Mario D'Souza, Steven C Kao, Janette L Vardy
INTRODUCTION: Earlier access to lung cancer specialist (LCS) care improves survival. We examined times to diagnosis and treatment of patients with lung cancer in rural and metropolitan New South Wales (NSW) Australia, benchmarked against recent timeframe recommendations. MATERIALS AND METHODS: Semistructured interviews of recently diagnosed patients with lung cancer from five NSW cancer centers were used to determine standardized time intervals to diagnosis and treatment, triangulated with Medicare data linkage and medical records...
September 12, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30207853/use-of-patient-reported-outcome-measures-in-quality-oncology-practice-initiative-registered-practices-results-of-a-national-survey
#4
Biqi Zhang, Whit Lloyd, Mohammad Jahanzeb, Michael J Hassett
PURPOSE: Measuring patient-reported outcomes (PROs) in clinical practice has been associated with improved survival and quality of life for patients with cancer. However, this application of PROs is relatively new, and little is known about how practices collect PROs, which PROs are measured, and what challenges are met in implementation. METHODS: We surveyed Quality Oncology Practice Initiative-registered practices in December 2015 to understand the current state of PROs use and identify areas where implementation support may be needed...
September 12, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30207852/comorbidity-assessment-in-the-national-cancer-database-for-patients-with-surgically-resected-breast-colorectal-or-lung-cancer-aft-01-02-03
#5
Melisa L Wong, Timothy L McMurry, Jessica R Schumacher, Chung-Yuan Hu, George J Stukenborg, Amanda B Francescatti, Caprice C Greenberg, George J Chang, Daniel P McKellar, Louise C Walter, Benjamin D Kozower
PURPOSE: Accurate comorbidity measurement is critical for cancer research. We evaluated comorbidity assessment in the National Cancer Database (NCDB), which uses a code-based Charlson-Deyo Comorbidity Index (CCI), and compared its prognostic performance with a chart-based CCI and individual comorbidities in a national sample of patients with breast, colorectal, or lung cancer. PATIENTS AND METHODS: Through an NCDB Special Study, cancer registrars re-abstracted perioperative comorbidities for 11,243 patients with stage II to III breast cancer, 10,880 with stage I to III colorectal cancer, and 9,640 with stage I to III lung cancer treated with definitive surgical resection in 2006-2007...
September 12, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30199312/clinically-localized-prostate-cancer-asco-clinical-practice-guideline-endorsement-of-an-aua-astro-suo-guideline-summary
#6
Justin E Bekelman, R Bryan Rumble, Stephen J Freedland
No abstract text is available yet for this article.
September 10, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30192693/human-papillomavirus-testing-in-head-and-neck-carcinomas-asco-clinical-practice-guideline-endorsement-summary-of-the-cap-guideline
#7
Carole Fakhry, Christina Lacchetti, Bayardo Perez-Ordonez
No abstract text is available yet for this article.
September 7, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30192692/continued-challenges-to-the-adoption-and-implementation-of-survivorship-care-plans
#8
Amye J Tevaarwerk, Mary E Sesto
No abstract text is available yet for this article.
September 7, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30179525/antimicrobial-prophylaxis-for-adult-patients-with-cancer-related-immunosuppression-asco-and-idsa-clinical-practice-guideline-update-summary
#9
Randy A Taplitz, Erin B Kennedy, Christopher R Flowers
No abstract text is available yet for this article.
September 4, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30133347/use-of-neoadjuvant-sunitinib-in-renal-cell-carcinoma-of-a-transplanted-kidney
#10
Nataliya Mar, Roozbeh Houshyar, Mark Jordan
No abstract text is available yet for this article.
August 22, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30133345/paraneoplastic-demyelinating-sensorimotor-neuropathy-delaying-the-diagnosis-of-an-underlying-acute-lymphoblastic-leukemia-in-a-child
#11
Rumesh Chandar, Shwetha Seetharam, Kaduveettil Gopinathan Gopakumar, Priya Appanraj, Guruprasad Cs, Binitha Rajeswari, Manjusha Nair, Priyakumari Thankamony
No abstract text is available yet for this article.
August 22, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30205776/head-and-neck-cancer-in-elderly-patients-what-to-do-when-data-are-limited
#12
Rafael Santana-Davila
No abstract text is available yet for this article.
September 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30205775/medical-marijuana-use-in-a-community-cancer-center
#13
Claire E Saadeh, Danielle R Rustem
PURPOSE: The primary purpose of this study was to compare the incidence of marijuana use between patients with early- versus advanced-stage cancers. Differences in adverse effects, drug-drug interactions, and drug-disease interactions between those who use marijuana and those who do not were also compared. METHODS: Patients age 18 years and older who were receiving chemotherapy were asked to complete an electronic self-reported questionnaire. In addition to questions about patient demographics, current adverse effects, cancer type and stage, comorbidities, performance status, treatment regimen, and general marijuana use, those patients who used marijuana within the last 30 days (current marijuana users) were asked additional questions about the route and frequency of marijuana administration, about reason(s) for use, about possession of a marijuana card, and if they had received any counseling about marijuana...
September 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30205774/navigating-through-new-first-line-treatment-options-for-lung-cancer
#14
Benjamin Solomon
No abstract text is available yet for this article.
September 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30205773/treatment-of-advanced-non-small-cell-lung-cancer-from-chemotherapy-to-chemoimmunotherapy
#15
Robert Pirker
No abstract text is available yet for this article.
September 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30205772/early-stage-oral-cavity-and-oropharyngeal-carcinoma-in-the-elderly-an-evolving-proposition
#16
William M Lydiatt
No abstract text is available yet for this article.
September 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30205771/first-line-therapies-for-metastatic-lung-adenocarcinoma-without-a-driver-mutation
#17
J Nicholas Bodor, Vineela Kasireddy, Hossein Borghaei
Lung cancer is the leading cause of cancer-related death worldwide. The majority of these cancers are non-small-cell lung cancer, of which adenocarcinoma is the most common histologic subtype. Most patients are diagnosed at advanced stages when systemic treatment is needed. Whereas prognosis has improved for patients with targetable driver mutations, the majority of patients do not possess tumors with such molecular mutations. Platinum-based chemotherapy has traditionally been the mainstay of treatment, although in recent years immunotherapy has emerged as a treatment option and can result in robust and durable treatment responses in a subset of patients...
September 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30138053/principles-for-the-oncologist-in-caring-for-muslim-patients
#18
Bilal Farooqi, Aadil Modi, Mohammad Omar Hussaini, Merry Jennifer Markham, Jennifer M Duff
No abstract text is available yet for this article.
September 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30138052/going-for-broke-a-longitudinal-study-of-patient-reported-financial-sacrifice-in-cancer-care
#19
Fumiko Chino, Jeffrey M Peppercorn, Christel Rushing, Jonathan Nicolla, Arif H Kamal, Ivy Altomare, Greg Samsa, S Yousuf Zafar
PURPOSE: Patients with cancer are at risk for substantial treatment-related costs; however, little is known about patients' willingness to sacrifice to receive cancer care and how their attitudes and burden may change with time. PATIENTS AND METHODS: We conducted a longitudinal survey of insured patients with solid tumor cancers receiving chemotherapy or hormonal therapy. Patients were surveyed at two time points about their willingness to make financial sacrifices and their actual sacrifices, including out-of-pocket costs...
September 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/30133346/understanding-the-role-of-advanced-practice-providers-in-oncology-in-the-united-states
#20
Suanna S Bruinooge, Todd A Pickard, Wendy Vogel, Amy Hanley, Caroline Schenkel, Elizabeth Garrett-Mayer, Eric Tetzlaff, Margaret Rosenzweig, Heather Hylton, Shannon N Westin, Noƫl Smith, Conor Lynch, Michael P Kosty, Stephanie F Williams
PURPOSE: Advanced practice providers (APPs, which include nurse practitioners [NPs] and physician assistants [PAs]) are integral members of oncology teams. This study aims first to identify all oncology APPs and, second, to understand personal and practice characteristics (including compensation) of those APPs. METHODS: We identified APPs who practice oncology from membership and claims data. We surveyed 3,055 APPs about their roles in clinical care. RESULTS: We identified at least 5,350 APPs in oncology and an additional 5,400 who might practice oncology...
September 2018: Journal of Oncology Practice
journal
journal
41216
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"